Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1)

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

(2014) Katrina J. Falkenberg et al.   NATURE REVIEWS DRUG DISCOVERY

Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease

(2013) Nobuhide Ueki et al.   Nature Communications

Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors

(2012) Geneviève P Delcuve et al.   Clinical Epigenetics

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Structural and Functional Studies of the Yeast Class II Hda1 Histone Deacetylase Complex

(2009) Jung-Hoon Lee et al.   JOURNAL OF MOLECULAR BIOLOGY

Strategies in developing promising histone deacetylase inhibitors

(2009) Lei Zhang et al.   MEDICINAL RESEARCH REVIEWS

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

(2008) Michael Haberland et al.   NATURE REVIEWS GENETICS